Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
...Ltd. ("Mayne") have filed a second lawsuit against impax Laboratories, Inc. ("Impax") in the District Court...o the U.S. Food and Drug Administration ("FDA") by impax requesting approval to manufacture and sell a gene... in December 2008, the filing of a lawsuit against impax in response to Impax's submission of an ANDA reque...Warner Chilcott Announces Receipt of FDA Response to Citizen Petition
...hat following the commencement of its anticipated infringement suit against impax Laboratories, Inc. ("Impax") it will be entitled to a 30-month stay of approval with respect to the impax ANDA for a generic version of DORYX 150 mg delayed-release tablets. D...Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
... received a Paragraph IV Certification Notice from impax Laboratories, Inc. ("Impax") advising that impax has filed an Abbreviated New Drug Application (AND...tail of the Paragraph IV Certification Notice from impax and intend to vigorously defend the 161 patent and...Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
...arner Chilcott previously announced the filing of similar lawsuits against each of Mutual Pharmaceutical Company, Inc., Mylan Pharmaceuticals Inc. and impax Laboratories, Inc. on December 23, 2008. The lawsuit is in response to the submission of an Abbreviated New Drug Application ("ANDAs") to the U....Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent
...ceutical Company, Inc. ("Mutual"), Mylan Pharmaceuticals Inc. ("Mylan") and impax Laboratories, Inc. ("Impax") in the District Court for the District of New... the U.S. Food and Drug Administration ("FDA") by each of Mutual, Mylan and impax requesting approval to manufacture and sell generic versions of DORYX 100 a...Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit
-- Federal Court Enters Consent Judgment Terminating Litigation -- MADISON, N.J., July 16 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE ) and Impax Laboratories Inc. today announced that all conditions of a settlement of the U.S. patent infringement litigation pertaining to Impax's proposed g...